Gain Therapeutics (GANX) files $100M mixed shelf

Gain Therapeutics (NASDAQ: GANX) has filed $100,000,000 mixed shelf of:

Common Stock
Preferred Stock
Warrants
Debt Securities
Subscription Rights
Units

You May Also Be Interested In

• Nuvectis Pharma (NVCT) files $200M mixed shelf
• Applied Optoelectronics sets up $600M at-the-market stock offering
• Oruka Therapeutics (ORKA) files $1B mixed shelf